CAS 160146-16-7

Finrazole

Description:

Finrazole is a chemical compound primarily recognized for its application in veterinary medicine, particularly as an anthelmintic agent. It belongs to the class of imidazoles and is characterized by its ability to inhibit certain enzymes in parasites, thereby disrupting their metabolic processes. The molecular structure of Finrazole includes a heterocyclic ring, which is essential for its biological activity. It is typically administered in formulations designed for livestock and pets to combat parasitic infections. Finrazole exhibits moderate solubility in organic solvents, which can influence its bioavailability and efficacy. Additionally, it has a relatively low toxicity profile, making it suitable for use in animals when administered at recommended dosages. As with many veterinary pharmaceuticals, the safety and effectiveness of Finrazole are subject to regulatory oversight, ensuring that it meets the necessary standards for use in animal health. Overall, Finrazole represents a significant tool in the management of parasitic diseases in veterinary practice.

Formula: C₁₈H₁₅FN₄O

InChI: InChI=1/C18H15FN4O/c19-16-7-3-13(4-8-16)9-17(24)18(23-12-21-11-22-23)15-5-1-14(10-20)2-6-15/h1-8,11-12,17-18,24H,9H2/t17-,18-/m1/s1

SMILES: c1cc(ccc1C#N)[C@H]([C@@H](Cc1ccc(cc1)F)O)n1cncn1

Synonyms:

• 4-[(1R,2R)-3-(4-Fluorophenyl)-2-hydroxy-1-(1,2,4-triazol-1-yl)propyl]benzonitrile
• 4-[(1R,2R)-3-(4-fluorophenyl)-2-hydroxy-1-(1H-1,2,4-triazol-1-yl)propyl]benzonitrile

Finrazole

CAS: 160146-16-7

Finrazole is a chiral compound that is used as an analog of the natural hormone estradiol. It has been shown to inhibit the production of fatty acids and inhibit aromatase activity in human endometrium cells. Finrazole is also effective in reducing prostate cancer cells in a model system. Chronic exposure to finasteride has been shown to cause cancer, although this effect may be due to its ability to bind with and activate the androgen receptor. Finasteride has also been shown to have anti-carcinogenic properties, which may be due to its ability to inhibit cell proliferation by binding with the androgen receptor.

Formula: C₁₈H₁₅FN₄O

Purity: Min. 95%

Molecular weight: 322.34 g/mol

Ref: 3D-FF101804

MPV-2213AD

CAS: 160146-16-7

MPV-2213AD is an aromatase inhibitor.

Formula: C₁₈H₁₅FN₄O

Color and Shape: Solid

Molecular weight: 322.34

Ref: TM-T70404